CMO Liu Dongfang sells 150,000 shares (89.3% of holdings) at $7.82; stock at 52-week high, fundamentals deteriorating
Liu Dongfang, Chief Medical Officer, sold 150,000 shares for $1,173,255.00, reducing his position from 168,000 shares to 18,000 shares—a 89.3% reduction in holdings. The sale occurred at $7.82 while the stock currently trades at $8.37, which is at its 52-week high, having appreciated 61.9% over 30 days and 144.7% over 90 days. Against this backdrop of sharp recent gains, the company remains deeply unprofitable with net income of $-55,792,000.00 against quarterly revenue of $13,120,000.00, indicating the CMO's substantial share reduction took place during a period of elevated valuation relative to deteriorating financial performance. The magnitude of the position reduction—retaining only 18,000 shares—represents a material shift in disclosed insider exposure to the company.